Jeffrey V. Poulton - Net Worth and Insider Trading

Jeffrey V. Poulton Net Worth

The estimated net worth of Jeffrey V. Poulton is at least $8 Million dollars as of 2024-11-05. Jeffrey V. Poulton is the EVP, CFO of Alnylam Pharmaceuticals Inc and owns about 28,949 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $8 Million. Details can be seen in Jeffrey V. Poulton's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey V. Poulton has not made any transactions after 2024-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jeffrey V. Poulton

To

Jeffrey V. Poulton Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey V. Poulton owns 3 companies in total, including Homology Medicines Inc (FIXX) , Alnylam Pharmaceuticals Inc (ALNY) , and CervoMed Inc (CRVO) .

Click here to see the complete history of Jeffrey V. Poulton’s form 4 insider trades.

Insider Ownership Summary of Jeffrey V. Poulton

Ticker Comapny Transaction Date Type of Owner
FIXX Homology Medicines Inc 2020-07-21 director
ALNY Alnylam Pharmaceuticals Inc 2024-06-25 Chief Financial Officer
CRVO CervoMed Inc 2023-08-16 director

Jeffrey V. Poulton Latest Holdings Summary

Jeffrey V. Poulton currently owns a total of 1 stock. Jeffrey V. Poulton owns 28,949 shares of Alnylam Pharmaceuticals Inc (ALNY) as of June 25, 2024, with a value of $8 Million.

Latest Holdings of Jeffrey V. Poulton

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALNY Alnylam Pharmaceuticals Inc 2024-06-25 28,949 265.97 7,699,566

Holding Weightings of Jeffrey V. Poulton


Jeffrey V. Poulton Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey V. Poulton has made a total of 4 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 1,605 shares on June 25, 2024, which brought Jeffrey V. Poulton around $370,755.

Insider Trading History of Jeffrey V. Poulton

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey V. Poulton Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey V. Poulton Ownership Network

Ownership Network List of Jeffrey V. Poulton

No Data

Ownership Network Relation of Jeffrey V. Poulton

Insider Network Chart

Jeffrey V. Poulton Owned Company Details

What does Homology Medicines Inc do?

Who are the key executives at Homology Medicines Inc?

Jeffrey V. Poulton is the director of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .

Homology Medicines Inc (FIXX) Insider Trades Summary

Over the past 18 months, Jeffrey V. Poulton made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Homology Medicines Inc Insider Transactions

No Available Data

Jeffrey V. Poulton Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey V. Poulton. You might contact Jeffrey V. Poulton via mailing address: 300 Third Street, Cambridge Ma 02142.